192 related articles for article (PubMed ID: 38596093)
1. Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis.
Shan W; Guan H; Gu H; Wang R; Huang X; Li P; Xie Y; Bao K; Qin X
Heliyon; 2024 Apr; 10(7):e28836. PubMed ID: 38596093
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
Lu Z; Liu W; Gao H; Chen W; Ge W; Li F; Deng Y
PLoS One; 2021; 16(5):e0251131. PubMed ID: 33989325
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of traditional Chinese medicine adjuvant therapy for severe pneumonia: evidence mapping of the randomized controlled trials, systematic reviews, and meta-analyses.
Xie K; Guan S; Jing H; Ji W; Kong X; Du S; Jia M; Wang H
Front Pharmacol; 2023; 14():1227436. PubMed ID: 37841930
[No Abstract] [Full Text] [Related]
7. Management of Membranous Nephropathy in Western Countries.
Alfaadhel T; Cattran D
Kidney Dis (Basel); 2015 Sep; 1(2):126-37. PubMed ID: 27536673
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
9. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials.
Tian Z; Li Y; Xie Y; Yang Y; Xu J
Int Urol Nephrol; 2022 Oct; 54(10):2555-2566. PubMed ID: 35277831
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of the integration of traditional Chinese medicine and western medicine in the treatment of diabetes-associated cognitive decline: a systematic review and meta-analysis.
Su J; Sun G; An J; Ao Y; Li J; Shen Z; Zhang L; Zhang S; Yang Y; Shi Y
Front Pharmacol; 2023; 14():1280736. PubMed ID: 38074157
[No Abstract] [Full Text] [Related]
12. Traditional Chinese medicine for the treatment of diabetic kidney disease: A study-level pooled analysis of 44 randomized controlled trials.
Liu X; Ge M; Zhai X; Xiao Y; Zhang Y; Xu Z; Zhou Z; Mei Z; Yang X
Front Pharmacol; 2022; 13():1009571. PubMed ID: 36313382
[No Abstract] [Full Text] [Related]
13. Chinese herbal medicine for oesophageal cancer.
Chen X; Deng L; Jiang X; Wu T
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004520. PubMed ID: 26799001
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of Huangqi ()-based Traditional Chinese Medicine in diabetic peripheral neuropathy: a Meta-analysis of randomized controlled trials.
Jing P; Hongzheng H; Zhenqi WU; Meijuan Z; Zuojing LI; Gang C
J Tradit Chin Med; 2024 Apr; 44(2):229-242. PubMed ID: 38504529
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
Lin W; Li HY; Lin S; Zhou T
Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-Analysis.
Zhou LP; Wang J; Xie RH; Pakhale S; Krewski D; Cameron DW; Wen SW
J Altern Complement Med; 2021 Mar; 27(3):225-237. PubMed ID: 33252246
[No Abstract] [Full Text] [Related]
18. A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.
Yu R; Zhang S; Zhao D; Yuan Z
Expert Rev Mol Med; 2022 Jan; 24():e5. PubMed ID: 34986905
[TBL] [Abstract][Full Text] [Related]
19. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: A prospective randomized controlled trial.
Lang R; Wang XH; Li AF; Liang Y; Zhu BC; Shi B; Zheng YQ; Yu RH
Chronic Dis Transl Med; 2020 Jun; 6(2):124-133. PubMed ID: 32596649
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
Qiu TT; Zhang C; Zhao HW; Zhou JW
Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
